Arcturus Therapeutics
ARCT
NZ$22.93
Share price
-4.83%
Change (1 day)
-40.94%
Change (1 year)
Arcturus Therapeutics (ARCT) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : NZ$0.16 Billion
According to Arcturus Therapeutics 's latest financial reports the company's total liabilities are NZ$0.16 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Arcturus Therapeutics - Total liabilities on balance sheet (from 2012 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | NZ$0.18 B | -23.39% |
| 2023-12-31 | NZ$0.23 B | -15.88% |
| 2022-12-31 | NZ$0.28 B | 17.69% |
| 2021-12-31 | NZ$0.24 B | 117.61% |
| 2020-12-31 | NZ$0.11 B | 32.35% |
| 2019-12-31 | NZ$83.67 M | 83.68% |
| 2018-12-31 | NZ$45.55 M | 77.47% |
| 2017-12-31 | NZ$25.66 M | 46.23% |
| 2016-12-31 | NZ$17.55 M | 410.79% |
| 2015-12-31 | NZ$3.43 M | 13.37% |
| 2014-12-31 | NZ$3.03 M | 52.26% |
| 2013-12-31 | NZ$1.99 M | 113.25% |
| 2012-12-31 | NZ$0.93 M | 232.7% |
| 2011-12-31 | NZ$0.28 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 NRC Health
NRC | NZ$0.17 B | 7.63% | 🇺🇸 USA |
 Nymox Pharmaceutical NYMX | NZ$5.23 M | -96.79% | Bahamas |